HUMAN LEUKOCYTE ANTIGEN-B27 AND DISEASE SUSCEPTIBILITY IN VOJVODINA, SERBIA
Vojvodić S1,*, Ademović-Sazdanić D1, Busarčević I2
*Corresponding Author: Assistant Professor Svetlana Vojvodić, M.D., Ph.D., Department for Laboratory Testing, Tissue Typing Compartment, Institute for Blood Transfusion of Vojvodina, Hajduk Veljkova 9a, 21000 Novi Sad, Serbia; Tel.: +381-21-4877-963; Mobile: +381-64-861-58-12; Fax: +381-21-4877-978; E-mail: ssvu@EUnet.rs
page: 55

REFERENCES

1. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saengen W, et al. HLA-B27 Subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem. 2002; 227(49): 47844-47853. 2. Popa OM, Bojinica M, Bojinica V, Ciofu C, Dutescu MI, Bardan A, et al.Distribution of HLAB27 in Romanian spondyloarthritides patients. Int J Immunogenet. 2010; 37(6): 513-516. 3. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Prion. 2009; 3(1): 15-26. 4. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology. 2002; 41(8): 857-868. 5. Huhtinen M. Acute anterior uveitis and HLAB27: infectious background, systemic inflamation and prognosis of the patients. Academic dissertation, defended at the Medical Faculty of the University of Helsinki, Helsinki, 2002. 6. Allen RL, Bowness P, McMichael AJ. The role of HLA-B27 in spondyloarthritis. Immunogenetics. 1999; 50(3-4): 220-227. 7. Marsh SGE. Nomenclature for factors of the HLA system, update September 2011. Int J Immunogenet. 2011; 39(1): 95-97. 8. Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-405. 9. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, et al. Increased level of HLA B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology. 2002; 41(12): 1375-1379. 10. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens. 1986; 25(5): 301-312. 11. Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. Transplant Proceedings. 1987; 19(1): 655-657. 12. Walker RH. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks, 1993: 305-307. 13. Stites DP, Stobo JD, Wells JV. Osnovna i klinička imunologija. Beograd: Savremena Administracija, 1989; 50-63. 14. Svejgaard A, Platz R, Ryder LP. HLA and disease 1982-A survey. Immunolog Rev. 1983; 70(1): 193-201. 15. Bengston BO, Thompson G. Measuring the strength of associations between HLA antigens and disease. Tissue Antigens. 1981; 18(5): 356-363. 16. Green A. The epidemiologic approach to studies of association between HLA and disease.II Estimation of absolute risk, etiologic and preventive fraction. Tissue Antigens. 1982; 19(4): 259-168. 17. Petz B. Osnovne statističke metode. Zagreb: Izdanja škole narodnog zdravlja “Andrija Štampar.” 1967: 111-134. 18. Snedecor GW, Cochan GW. Statistical Methods. Ames: The Iowa State University Press. 1956: 219-221. 19. Emam SJ, Badri S, Bayat A, Dashtebozorg N, Khosravi A. Evaluation of 278 HLA-B27 positive patients suspected of seronegative spondyloarthropathies. Pakistan J Med Sci. 2007; 23(5): 728-732. 20. McMichael A, Bowness P. HLA-B27:natural function and pathogenic role in spondyloarthritis. Arthritis Res. 2002; 4(Suppl 3): S153-S158. 21. Sahin S, Aydogan L, Benli I, Ozyurt H. Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey. Genet Molec Res. 2011; 10(4): 3987-3991. 22. Sheehan NJ. The ramifications of HLA-B27. J Roy Soc Med. 2004; 97(1): 10-14. 23. Dhurandhar PS, Shankarkumar U. HLA Association in seronegative spondyloarthritis patients from Mumbai, India. Int J Hum Genet. 2007; 7(3): 235-239. 24. Pitchappan RM, Balakrlshnan K, Mahendran V, Brahmajathi V. HLA and disease susceptibility in Tamil Nadu, S. India. Indian J Hum Genet. 1995; 1(1):56-62. 25. Kim T-H, Uhm W-S, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005; 17(4): 400-405. 26. Colmegna I, Cuchacovich R, Espinoza LR. HLA- B27 associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17(2): 348-369. 27. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheumatic Dis Clin North Am. 2009; 35(1): 21-44. 28. FitzGerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009; 11(1): 214-223. 29. Khairallah M,Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007; 21(1): 33-39. 30. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27: what’s new? In: Pleyer U, Forrester JV, Eds. Uveitis and Immunological Disorders. Heidelberg: Springer- Verlag. 2009:9-17. 31. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Survey Ophtalmol. 2005; 50(4): 364-388. 32. Mishra MN, Bharucha KM. HLA-B27 Association with uveitis in an Asian Indian population. Iranian J Immunol. 2011; 8(2): 85-89.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006